See the Full Picture.
Get Started
SubscribeLogin
Eurovision
Cannes Film Festival
Baseball
Social Media
NCAA
Natural Disasters
WWE
Manchester United
Instagram
Artificial Intelligence
Israel-Hamas Conflict
Published • loading... • Updated

Teclistamab is Feasible for Select Elderly Patients with Multiple Myeloma

Summary by cancernetwork.com
CRS and ICANS occurrence were comparable for patients with relapsed/refractory multiple myeloma 75 years and older vs those younger than 75.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
cancernetwork.comcancernetwork.com

Teclistamab is Feasible for Select Elderly Patients with Multiple Myeloma

CRS and ICANS occurrence were comparable for patients with relapsed/refractory multiple myeloma 75 years and older vs those younger than 75.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

cancernetwork.com broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal